ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Florida Creates State Cancer Control Program

August 10, 1979

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

NCI-Approved CTEP Trials For the Month of December

December 28, 2012

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005